Gastroenterology and hepatology
Inflammatory bowel disease, fatty liver and cirrhosis, hepatitis, advanced endoscopy, Helicobacter, colorectal cancer screening and pancreas.
Published issues
- What's next in gastroenterology — November 17, 2026
This edition gathers four milestones with verifiable dates between late November 2026 and March 2027: topline results from a phase 3 MASH trial, two FDA decisions (gastrointestinal stromal tumor and pediatric…
🎧 ListenAudio newscast · 4:03 min - Monthly gastroenterology and hepatology bulletin — November 7, 2026
Colleagues: this issue covers October 8 to November 7, 2026. The month was dominated by three meetings: the scientific sessions of the ACG Annual Scientific Meeting (Nashville, October 12–14), UEG Week 2026 (Barcelona,…
🎧 ListenAudio newscast · 6:23 min - What's next in gastroenterology — October 17, 2026
This issue covers what is coming in gastroenterology and hepatology between mid-October 2026 and April 2027: an FDA decision in hepatitis B, two congresses with new data (UEG Week and The Liver Meeting), and a pediatric…
🎧 ListenAudio newscast · 3:38 min - Monthly gastroenterology and hepatology bulletin — October 8, 2026
Colleagues: this issue covers September 8 to October 8, 2026. The month was dominated by hepatology (a phase 3 trial in hepatitis delta), an ACG guideline on preventive care in cirrhosis, a European trial that may…
🎧 ListenAudio newscast · 5:10 min - Monthly gastroenterology bulletin — September 28, 2026
Colleagues: this issue covers what was published, presented or approved between August 28 and September 28, 2026. It was a month with more regulatory and industry signals than phase 3 trials published in journals; in…
🎧 ListenAudio newscast · 5:24 min